Delivery Order SPE2DB20D3303-SPE2DB25FA1VP
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $6,518.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order executed under an existing contract vehicle and requires fulfillment within an...
- The Defense Logistics Agency awarded a delivery order valued at $15,184.50 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injectors on July 24, 2025, with completion expected by July 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was issued without set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,430.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader pharmaceutical...
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $3,826.25 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections with a ceiling value of $2,178.54. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.48 to AmerisourceBergen Drug Corp for supply of Zepbound 2.5 mg/0.5 mL pen injectors on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate office and primary pharmaceutical distribution hub for federal...
- The Defense Logistics Agency awarded a $6,148.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract is non-set-aside and competitively awarded, with performance taking place at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $26,135.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors on a firm fixed price basis. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a competitively awarded procurement with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1VPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors valued at $6,100.68. This firm fixed-price, non-set-aside contract is scheduled for completion by July 29, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support to military healthcare programs worldwide and encompasses a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 7/28/25 |